These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3247413)

  • 1. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte subpopulations in leprosy patients and their relation with circulating immune complexes.
    Bottasso OA; Morini JC; Ramos G; Segal-Eiras A
    Allergol Immunopathol (Madr); 1990; 18(2):91-4. PubMed ID: 2142569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the methods for early serological diagnosis of leprosy and their potential use.
    Wu Q; Li X; Yin Y; Shu H; Wei W; Liu Q; Ye G
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):302-5. PubMed ID: 10575411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of myelin basic proteins in circulating immune complexes associated with lepromatous leprosy.
    Córsico B; Croce MV; Mukherjee R; Segal-Eiras A
    Clin Immunol Immunopathol; 1994 Apr; 71(1):38-43. PubMed ID: 7511083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
    Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
    Mathew JM; Muthukkaruppan V
    Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection in lepromatous and tuberculoid patients from Senegal.
    Yvonnet B; Vincelot P; Millan J; Lesage G; Denis F; Languillon J; Mboup S; Coursaget P; Diop Mar I; Chiron JP
    Acta Leprol; 1989; 7(1):63-6. PubMed ID: 2624077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
    Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
    Segal-Eiras A; Croce MV; Ramos GS; Córsico B
    Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.
    Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M
    Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional state of the complement system in leprosy.
    Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
    Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
    Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
    J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
    Dornelles LN; Pereira-Ferrari L; Messias-Reason I
    Clin Exp Immunol; 2006 Sep; 145(3):463-8. PubMed ID: 16907914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.